Deutsche Bank’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-65
Closed -$585 3673
2024
Q1
$585 Sell
65
-1,607
-96% -$19.2K ﹤0.01% 3593
2023
Q4
$18.6K Buy
1,672
+1,074
+180% +$12K ﹤0.01% 3500
2023
Q3
$10.6K Sell
598
-603
-50% -$22K ﹤0.01% 3554
2023
Q2
$66K Buy
1,201
+8
+0.7% +$510 ﹤0.01% 3415
2023
Q1
$81.3K Buy
1,193
+378
+46% +$29.4K ﹤0.01% 3413
2022
Q4
$49.4K Buy
815
+12
+1% +$1.11K ﹤0.01% 3581
2022
Q3
$81K Sell
803
-118
-13% -$13.7K ﹤0.01% 3431
2022
Q2
$81K Buy
+921
New +$113K ﹤0.01% 3608
2021
Q3
Sell
-11,078
Closed -$3.31M 4623
2021
Q2
$3.31M Sell
11,078
-20,948
-65% -$6.24M ﹤0.01% 1802
2021
Q1
$9.55M Buy
+32,026
New +$9.8M 0.01% 1220

Other funds holding RBOT

Deutsche Bank's RBOT Position: Q2 2024 in Review

Deutsche Bank sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 65 shares — an estimated $585 sold.

Deutsche Bank first reported a position in RBOT in Q1 2021 and held it in 10 quarters. The position peaked at $9.55M in Q1 2021. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Deutsche Bank reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 65 Vicarious Surgical shares in Q2 2024, an estimated $585.
  • Deutsche Bank first reported a position in Vicarious Surgical in Q1 2021 and held it in 10 quarters.
  • Deutsche Bank's Vicarious Surgical position peaked at $9.55M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.